Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Laryngeal framework surgery: current strategies

Hess, Markus M.; Fleischer, Susanne

Current Opinion in Otolaryngology & Head and Neck Surgery: December 2016 - Volume 24 - Issue 6 - p 505–509
doi: 10.1097/MOO.0000000000000308

Purpose of review Laryngeal framework surgery (LFS) is an indispensable surgical approach for the treatment of voice problems. The purpose of this review is to single out some relevant articles published on the topic of LFS from 2015 to mid-2016. Articles referring to injection laryngoplasty (augmentation) are entirely left aside.

Recent findings In the vast majority of recent publications, LFS mostly addresses surgery intended to improve vocal function in cases of glottic insufficiency. Here, medialization laryngoplasties remain the most important surgery. Arytenoid adduction remains an important technique within this field. Some clinical studies concerning indications and outcome of LFS are covered in the recent articles, trying to improve decision making for the indication of medialization laryngoplasty to enhance the rate of favorable long-term results. As in the past years, only a few articles report on laboratory research and other aspects of LFS.

Summary Articles published from 2015 to mid-2016 show that further improvements in LFS have been made, both surgically–technically and in respect of patient selection. There is still a debate about the combination of medialization laryngoplasty and arytenoid adduction in patients with unilateral vocal fold paralysis or paresis (UVFP). Although augmentation laryngoplasties are significantly increasing in number, it seems that LFS remains an important procedure within phonosurgery.

aDeutsche Stimmklinik (German Voice Clinic), Hamburg, Germany

bDepartment of Voice, Speech and Hearing Disorders, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Correspondence to Dr Markus M. Hess, MD, Head, Deutsche Stimmklinik (German Voice Clinic), Martinistrasse 64, D-20251 Hamburg, Germany. Tel: +49 40 51313007; fax: +49 40 51313009; e-mail:

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.